VB-111: a novel anti-vascular therapeutic for glioblastoma multiforme
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
VB-111: a novel anti-vascular therapeutic for glioblastoma multiforme
Authors
Keywords
Glioblastoma, VB-111, Angiogenesis, Gene therapy, Tumor vasculature
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 124, Issue 3, Pages 365-372
Publisher
Springer Nature
Online
2015-06-24
DOI
10.1007/s11060-015-1853-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed + Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel + Carboplatin + Bevacizumab Followed by Maintenance Bevacizumab in Patients ith Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Ralph G. Zinner et al. Journal of Thoracic Oncology
- The predictive and prognostic value of the Glasgow Prognostic Score in metastatic colorectal carcinoma patients receiving bevacizumab
- (2014) Marianne Maillet et al. ANTI-CANCER DRUGS
- Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide
- (2014) Lucio Tentori et al. BMC CANCER
- Novel Paracrine Modulation of Notch-DLL4 Signaling by Fibulin-3 Promotes Angiogenesis in High-Grade Gliomas
- (2014) M. S. Nandhu et al. CANCER RESEARCH
- Bevacizumab: A Review of Its Use in Advanced Cancer
- (2014) Gillian M. Keating DRUGS
- The role of bevacizumab in recurrent, platinum-sensitive ovarian cancer
- (2014) Ajit Gubbi et al. Expert Review of Anticancer Therapy
- Bevacizumab-related toxicities in the National Cancer Institute malignant glioma trial cohort
- (2014) Yazmin Odia et al. JOURNAL OF NEURO-ONCOLOGY
- Mechanisms of Glioma Formation: Iterative Perivascular Glioma Growth and Invasion Leads to Tumor Progression, VEGF-Independent Vascularization, and Resistance to Antiangiogenic Therapy
- (2014) Gregory J. Baker et al. NEOPLASIA
- Phase I Dose-Escalation Study of VB-111, an Antiangiogenic Virotherapy, in Patients with Advanced Solid Tumors
- (2013) A. J. Brenner et al. CLINICAL CANCER RESEARCH
- FA-loaded lipid drug delivery systems: Preparation, characterization and biological studies
- (2013) Claudia Carbone et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme
- (2013) Yasushi Soda et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Rhenium-186 liposomes as convection-enhanced nanoparticle brachytherapy for treatment of glioblastoma
- (2012) W. T. Phillips et al. NEURO-ONCOLOGY
- Dynamic magnetic resonance imaging assessment of vascular targeting agent effects in rat intracerebral tumor models
- (2010) L. L. Muldoon et al. NEURO-ONCOLOGY
- Bevacizumab
- (2009) James E Frampton et al. BIODRUGS
- VEGF Trap induces antiglioma effect at different stages of disease
- (2008) Candelaria Gomez-Manzano et al. NEURO-ONCOLOGY
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started